Huike Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Huike Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Baoqing Sun
State Key Laboratory of Respiratory Disease The First Affiliated Hospital of Guangzhou Medical University Guangzhou China
1 shared publication Guilin Huang
School of Stomatology, Zunyi Medical University, Zunyi, Guizhou, China
1 shared publicationJia Tian
School of Stomatology, Zunyi Medical University, Zunyi, Guizhou, China
1 shared publicationJie Yi
School of Stomatology, Zunyi Medical University, Zunyi, Guizhou, China
1 shared publicationLi Yao
1 shared publication- Mingshan Xue
Department of Clinical Laboratory , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou 510000 , Guangdong , China , gzhmc.edu.cn
1 shared publication
Latest Publications
- 22 May 2024
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 100 (7) , 996-1008
Emerging role of mesenchymal stem cell-derived exosome microRNA in radiation injury
PurposeRadiation injury (RI) is a common occurrence in malignant tumors patients receiving radiation therapy. While killing tumor cells, normal tissue surrounding the target area is inevitably irradiated at a certain dose, which can cause varying results of radiation injury. Currently, there are limited clinical treatments available for radiation injuries. In recent years, the negative effects of stem cell therapy have been reported more clearly and non-cellular therapies such as exosomes have become a focus of attention for researchers. As a type of vesicle-like substances secreted by mesenchymal stem cells (MSC), MSC derived exosomes (MSC-exo) carry DNA, mRNA, microRNA (miRNAs), specific proteins, lipids, and other active substances involved in intercellular information exchange. miRNAs released by MSC-exo are capable of alleviating and repairing damaged tissues through anti-apoptosis, modulating immune response, regulating inflammatory response and promoting angiogenesis, which indicates that MSC-exo miRNAs have great potential for application in the prevention and treatment of radiation injury. Therefore, it is necessary to explore the underlying therapeutic mechanisms of MSC-exo miRNAs in this process, which may shed new lights on the treatment of radiation injury.ConclusionsIncreasing evidence confirms that MSC-exo has shown encouraging applications in tissue repair due to the anti-apoptotic, immunoreactive, and pro-angiogenesis effects of the miRNAs it carries as intercellular communication carriers. However, miRNA-based therapeutics are still in their infancy and many practical issues remain to be addressed for clinical applications.
- 22 May 2024
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 100 (7) , 996-1008
Emerging role of mesenchymal stem cell-derived exosome microRNA in radiation injury
PurposeRadiation injury (RI) is a common occurrence in malignant tumors patients receiving radiation therapy. While killing tumor cells, normal tissue surrounding the target area is inevitably irradiated at a certain dose, which can cause varying results of radiation injury. Currently, there are limited clinical treatments available for radiation injuries. In recent years, the negative effects of stem cell therapy have been reported more clearly and non-cellular therapies such as exosomes have become a focus of attention for researchers. As a type of vesicle-like substances secreted by mesenchymal stem cells (MSC), MSC derived exosomes (MSC-exo) carry DNA, mRNA, microRNA (miRNAs), specific proteins, lipids, and other active substances involved in intercellular information exchange. miRNAs released by MSC-exo are capable of alleviating and repairing damaged tissues through anti-apoptosis, modulating immune response, regulating inflammatory response and promoting angiogenesis, which indicates that MSC-exo miRNAs have great potential for application in the prevention and treatment of radiation injury. Therefore, it is necessary to explore the underlying therapeutic mechanisms of MSC-exo miRNAs in this process, which may shed new lights on the treatment of radiation injury.ConclusionsIncreasing evidence confirms that MSC-exo has shown encouraging applications in tissue repair due to the anti-apoptotic, immunoreactive, and pro-angiogenesis effects of the miRNAs it carries as intercellular communication carriers. However, miRNA-based therapeutics are still in their infancy and many practical issues remain to be addressed for clinical applications.
- Open Access
- 1 May 2020
- Published by Oxford University Press (OUP)
- p. A2374
Evaluation of the Diagnostic Efficacies of Serological Markers Kl-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia
- 1 May 2020
- Published by Oxford University Press (OUP)
- p. A2374
Open AccessEvaluation of the Diagnostic Efficacies of Serological Markers Kl-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia